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Recognition of Pneumococcal Peptidoglycan:
An Expanded, Pivotal Role for LPS Binding Protein
attached teichoic acid (TA) chains. This combination of
surface elements induces the especially intense inflam-
matory response recognized by clinicians to be charac-
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Germany complement activation and promotes phagocytosis but
3 Department of Immunochemistry is not known to induce proinflammatory signaling
and Biochemical Microbiology (Holzer et al., 1984). Phosphorylcholine on the pneumo-
Research Center Borstel coccal surface also binds to the platelet activating factor
Center of Medicine and Bio-Sciences (PAF) receptor (Cundell et al., 1995). However, rather
28845 Borstel than signaling via G-proteins like the chemokine PAF,
Germany bacterial binding to the PAF receptor leads to endocyto-
4 Department of Infectious Diseases sis and bacterial invasion of eukaryotic cells (Ring et al.,
St. Jude Children’s Research Hospital 1998). Thus, the known interactions of PCW with the
Memphis, Tennessee 38105 innate immune system do not explain the majority of
features of pneumococcal inflammation.
Purified PCW induces meningeal inflammation indis-
Summary tinguishable from meningitis caused by living bacteria
in the early phase of the disease (Tuomanen et al., 1985;
Lipopolysaccharide binding protein (LBP) has a well- Weber et al., 1995). In vitro, purified PCW induces the
established role in LPS-induced immune responses. release of TNF- from astrocytes and brain microvascu-
Here, we report that LBP also plays an essential role
lar endothelial cells (BMEC) as well as numerous cyto-
in the innate immune response to Gram-positive
kines and chemokines from microglia (Freyer et al.,
pneumococci, specifically to their major inflammatory
1999). The signal transduction events involved in this
component, pneumococcal cell wall (PCW). LBP was
activation process include phosphorylation and activa-present in the CSF of patients with meningitis, and
tion of the MAP kinases erk 1/2 and p38 (Schumann etLBP-deficient mice failed to develop meningeal inflam-
al., 1998), as well as the translocation of the transcriptionmation. LBP enhanced PCW-induced cell signaling
factor NF-B (Spellerberg et al., 1996). In astrocytes andand TNF- release. LBP bound specifically to PCW
in THP-1 cells, the effect of the purified PCW seemsmultimers, indicating novel lipid-independent binding
to be partially CD14 dependent (Cauwels et al., 1997;capability for LBP. We propose the iterative anionic
Schumann et al., 1998). Recently, it has been shown thatgroups along the glycan backbone of the cell wall
heat-killed pneumococci and soluble pneumococcal PGare a crucial structure for recognition by LBP. Such a
induce signaling by a member of the family of toll-likefunction for LBP expands its role to Gram-positive
receptors TLR-2 (Yoshimura et al., 1999). The immuno-infections.
stimulatory effect of soluble, fragmented PCW is clini-
cally of significant importance because of the tremen-Introduction
dous increase in its release during antibiotic-induced
lysis of bacteria (Tuomanen et al., 1987; Schneider etStreptococcus pneumoniae is the major pathogen caus-
al., 1999; Fischer and Tomasz, 1984). This process pre-ing community-acquired pneumonia and bacterial men-
sents a large library of chemically diverse, soluble, andingitis in Europe and the US (Dowell et al., 2000; Schu-
insoluble PCW fragments to the innate immune re-chat et al., 1997). Especially devastating even in the
sponse apparatus, all of which must be recognized andcontext of modern antibiotics is the 34% mortality of
detoxified or inflammation will persist.pneumococcal meningitis (de Gans and van de Beek,
Lipopolysaccharide binding protein (LBP) is an acute2002). Despite its medical importance, the molecular
phase protein synthesized mainly in the liver but also inmechanisms of pneumococcal interactions with the in-
pulmonary and gastrointestinal epithelia cells (Vreugdenhilnate immune system are still surprisingly poorly under-
et al., 2000). LBP was first recognized for its ability tostood. Being a Gram-positive pathogen, pneumococcus
bind endotoxin (LPS) (Ulevitch and Tobias, 1995; Raetzlacks the familiar endotoxin that drives the majority of
Gram-negative immune responses. Rather, the pneumo- and Whitfield, 2002) and directs it to host cellular recep-
coccal cell surface is composed of membrane-bound tors (Schumann et al., 1990). Recently, it has been shown
lipoteichoic acid (LTA) encased in a cell wall consisting that it also binds to glycolipids of spirochetes, myco-
of a multilayered network of peptidoglycan (PG) with bacteria (Hermann et al., 2002; Savedra et al., 1996),
and lipoteichoic acid of Gram-positive bacteria (Fan et
al., 1999; Schroder et al., 2000, 2003), all by a process*Correspondence: joerg.weber@charite.de
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Figure 1. Requirement for LBP for Induction
of Meningeal Inflammation by PCW
All mice except controls were challenged in-
trathecally with PCW at the beginning of the
experiment. One group of LBP/ was recon-
stituted with exogenous, intrathecal murine
rLBP (0.5 g) at 0 hr and leukocytes counted
at 6 hr (n  6). rLBP alone had no effect in
LBP/ and LBP/ (n  3, n  2; 5 leuko-
cytes/l as PBS controls). # indicates a differ-
ence between the LBP/ ([A] black bar; [B]
closed circle) and PCW-injected mice (n  7)
compared to controls (n  5; p  0.05); *
indicates a statistically significant decrease
in LBP/ ([A] white bar; [B] open circle; n 
7; p  0.05, ANOVA, Student-Newman-Keuls
test).
directed toward recognition of lipid linked to carbohy- Results
drate structures. LBP enhances the binding of one frag-
ment of staphylococcal peptidoglycan to sCD14 (Dziar- The Role of LBP in Pneumococcal Meningitis
To verify the presence of LBP at a site of pneumococcalski et al., 1998). LBP is present at 5–10 g/ml in human
serum, and this concentration increases dramatically inflammation in vivo, LBP concentrations were mea-
sured in the CSF of patients with culture-proven pneu-during the acute phase response (Zweigner et al., 2001),
including in Gram-positive sepsis (Blairon et al., 2003). In mococcal meningitis and in controls with normal CSF
chemistry. Significantly higher LBP concentrations werelow concentrations, LBP enhances LPS-effects in vitro.
However, high concentrations such as that present in found in CSF of meningitis patients (228  193 ng/ml,
n  5) compared to controls (10  12 ng/ml, n  8;serum during sepsis attenuate LPS inflammation and
enable the host to detoxify LPS (Lamping et al., 1998; p  0.003, Mann-Whitney Rank Sum Test). A further
indication for the potential role of LBP to be a mediatorZweigner et al., 2001; Hamann et al., 2000). The LBP
knockout mouse has been shown to fail to initiate an in this context is the finding that pneumococcal cell wall
coprecipitated with LBP in the CSF of a patient withinflammatory response to LPS (Jack et al., 1997; Wurfel
et al., 1997) and is more susceptible to lethal infection confirmed meningitis (data not shown).
To ascribe a biological role for LBP in pneumococcalwith living Gram-negative bacteria (Fierer et al., 2002;
Heinrich et al., 2001; Yang et al., 2002). inflammation, the course of meningitis was compared
in heterozygous LBP/ mice and LBP/ mice. Hetero-Although the crystal structure of LBP has not been
elucidated yet, a series of residues essential for LPS zygous LBP/ mice (exhibiting levels of LBP equal to
wild-type littermates (Jack et al., 1997), experienced anbinding has been identified by mutagenesis, and the
corresponding LBP mutants lacking LPS binding have equivalent and brisk influx of leukocytes into the CSF
by 6 hr (Figure 1A), and histopathological analyses con-been functionally analyzed (Lamping et al., 1996; Schu-
mann et al., 1997). Based on significant overall sequence firmed severe meningitis (data not shown). In contrast,
leukocyte influx was markedly decreased in LBP/micesimilarities and mutagenesis data, a model of the three-
dimensional structure of human LBP has been deduced at 6 hr (Figure 1A), an effect that persisted at 12 and 24
hr (Figure 1B). Intrathecal administration of recombinantusing the boomerang-like crystal structure of human
bactericidal/permeability increasing protein (BPI) (Beamer murine LBP (rLBP) in the LBP/ mice restored PCW-
induced leukocyte influx and meningitis to levels inet al., 1997, 1998b, 1998a).
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Figure 2. Effect of LBP on PCW-Induced
Phosphorylation of erk1/2 Kinases and Induc-
tion of TNF- Production in Vitro
Cells were stimulated with PCW in the pres-
ence and absence of LBP. TNF or NO was
measured in the supernatants or cells were
harvested for MAPK-assay and Western blot-
ting. (A) Assessment of MAP kinase activity
in BMEC cells at 30 min. (B) Detection of
phosphorylation of erk1/2 in primary BMEC
cells at 30 min by Western blot. (C) Amount of
TNF- secreted into the supernatant of BMEC
and (D) RAW 264.7 cells at 6 hr. * indicates
a statistically significant difference p  0.01
compared to the stimulation without LBP.
LBP/ animals (Figure 1A). Consistent with this de- phorylation of erk1/erk2 in a dose-dependent manner
(Figure 2B). The phosphorylation was accompanied bycreased inflammatory response capability, LBP/ mice
challenged with living pneumococci showed decreased increased MAP kinase activity assessed by an MBP
assay that was rLPB dependent (Figure 2A). Kinase ac-leukocytosis in the CSF after 24 hr (133 96 leukocytes/
l versus 667  134; p  0.001; n  5 per group). tivity reached a maximum at 0.5 g/ml rLBP, a value
consistent with the concentration of LBP documentedInfection was confirmed by	106 CFU/ml CSF (no statis-
tically significant difference between the groups); all ani- in vivo. Higher concentrations of LBP reduced tyrosine
phosphorylation and activity of erk1/erk2 in a fashionmals survived the 24 hr experiment.
similar to that recently observed for LPS-dependent cel-
lular activation (Lamping et al., 1998; Hamann et al.,PCW-Induced Cellular Signaling Is Increased
by LBP 2000).
To determine if LBP participates in this arm of pneumo-
coccal-induced signaling, BMEC were stimulated with Effect of LBP on PCW-Induced TNF-
and NO ReleasePCW in the absence and presence of murine rLBP, and
tyrosine phosphorylation of erk1/erk2 was assessed by In order to determine the proinflammatory conse-
quences of LBP-dependent PCW-induced signaling, theWestern blot. LBP enhanced the PCW-induced phos-
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an apparent KD of 103  20 nM (Figure 4A). The amount
of binding also varied as a function of the concentration
of PCW attached to the ELISA plate (Figure 4B). LBP
binding at 5 and 10 g/ml was comparable to that ob-
served for the anti-phosphorylcholine antibody TEPC-
15. Intact pneumococcus was also recognized by LBP
in a dose-dependent manner (Figures 4C and 4D).
LBP Does Not Bind to the Phosphorylcholine
Groups of PCW
To determine if the phosphorylcholine adduct serves as
a substrate for LBP, PCW containing varying amounts
of phosphorylcholine were made. LBP binding to PCW
was not affected by the absence (ethanolamine substi-
tuted PCW) or decrease of choline content (PCW licD2
mutant; Figure 5A). In contrast, anti-choline TEPC-15 Ab
binding to the ethanolamine-substituted pneumococcal
wall was abrogated and binding to the licD2 mutant
PCW was decreased (Figure 5B).
Minimal Structure of PCW Required
for LBP-Dependent Bioactivity
PCW is a complex polymer built from two major parts,
peptidoglycan (PG) and teichoic acid (TA). To determineFigure 3. Dependence of Cellular Activation by PCW on TLR-2
which of the two components was critical to LBP-depen-HEK293 cells stably transfected with CD14 and MD-2 and bearing
dent bioactivity, PCW and TA-free PCW were tested forthe NF-B-dependent ELAM promoter driving 
 galactosidase and
the ability to induce LBP-dependent TNF- release fromluciferase expression were challenged with PCW.
(A) Cells transfected with TLR-2 responded to lipoprotein (LP) as a RAW 264.7 cells. Both PCW preparations demonstrated
positive control and to PCW (107 CFU equivalents, p  0.001 versus equivalent bioactivities, and these activities were
control; 106 CFU equivalents yielded 1.06  0.23 rel. light units p  equally augmented by LBP (Figure 5C). This implies that
0.03 versus control).
the teichoic acid chains are not required for bioactivity(B) Cells transfected with TLR-4 did not respond to PCW but did
or for LBP recognition of PCW.respond to LPS (100 ng/ml).
Having eliminated the TA, we enzymatically dissected
the PG into components to determine the minimal bioac-
tive structure. Digesting PCW with N-acetylmuramyl-effect of LBP on PCW-induced TNF- release was deter-
mined. rLBP alone had no effect compared to PBS- L-alanine amidase severs the stem peptides from the
glycan backbone, yielding high molecular weight glycantreated cells (RAW cells: 84.6  4.3 versus 78  3.0 pg/
ml; BMEC 3.2  4.5 versus 5.2  6.9). Addition of rLBP chains and a mixture of free monomeric and multimeric
peptides. Although amidase-treated PCW inducedsignificantly enhanced PCW-induced TNF- release
both from CD14 negative BMECs (Figure 2C) and to about half the TNF- compared to whole PCW, addition
of LBP still doubled the TNF- release, an amplitudean even greater degree from the CD14 positive murine
macrophage cell line RAW 264.7 (Figure 2D). Addition similar to that seen with whole PCW (Figure 5C). This
result suggested that a multimeric backbone was impor-of 0.5 g rLBP shifted the threshold of PCW induced
TNF- release one order of magnitude in both cell types. tant to LBP recognition. This was confirmed by two
further results. Degradation of the glycan chains of thePCW-induced production of nitric oxide was not modi-
fied by addition of rLBP in BMEC (no LBP, 63.8  3.2 amidase product to disaccharide fragments by murami-
dase greatly decreased bioactivity and LBP augmen-g/ml nitrite; 0.1 g/ml LBP, 64.9  2.7; 0.5 g/ml LBP,
67.2 1.1; 1g/ml LBP, 70 4) and was also unchanged tation (Figure 5C). Digestion of whole PCW only with
muramidase so as to produce a fragmented glycanin RAW 264.7 cells (data not shown).
backbone still maintained as a multimer by crosslinked
stem peptides, yielded material of intermediate bioactiv-TLR-2 Transduces the PCW Response
HEK293 cells devoid of TLR’s did not respond to PCW, ity that still showed augmentation by LBP (Figure 5C).
Thus, LBP doubled the bioactivity of PCW maintainedLPS, or lipopeptide (LP; data not shown). Transfection
with hTLR-2 resulted in strong activation of NF-B after as a multimer by glycan or peptide crosslinking, or both.
Thus, although the inherent bioactivity of PCW withoutstimulation with PCW and LP, but not LPS (Figure 3A),
whereas cells transfected with hTLR-4 responded to LBP did not survive loss of glycan backbone integrity,
the bioactivity of such floppy PG held together only byLPS, but not LP or PCW (Figure 3B).
peptide crosslinks could be salvaged by presentation
on the framework of LBP.Binding of LBP to the Pneumococcal Cell Wall
and Intact Pneumococci If LBP provides a scaffold to stabilize multimeric PG,
then immobilizing PG fragments would be predicted toBinding of LBP to immobilized PCW or intact pneumo-
cocci was measured in an ELISA format. LBP bound to at least partially reconstitute recognition of even small
fragments. Direct binding of LBP to immobilized PCWPCW in a saturable and dose-dependent fashion with
LBP and Pneumococci
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Figure 4. Direct Binding of LBP to PCW and
Intact Pneumococci
PCW (A and B) or intact pneumococci (C and
D) were bound to a microtiter plate, and the
ability to capture LBP was measured by
ELISA. Attachment of PCW to the ELISA plate
was confirmed by detection of capture of anti-
phosphorylcholine mAb TEPC-15 (B and D).
(A) Binding of LBP to PCW in a saturable and
dose-dependent fashion.
(B) Binding of LBP to PCW as a function of
cell wall and LBP concentration (50  5 
106 CFU equivalents).
(C) Binding of LBP to intact pneumococci (5
106 CFU equivalents) as a function of LBP
concentration.
(D) Binding of LBP (1 g/ml LBP) to intact
pneumococci as a function of bacterial con-
centration (100  2  107 CFU equivalents).
fragments was tested in the ELISA assay. The amidase- cantly reduced the capacity to bind to immobilized PCW
in a concentration-dependent fashion (Figure 6A). Astreated preparation (intact glycan backbone and free
peptides) captured as much LBP as whole PCW (97  binding of human rLBP to LPS has been shown to criti-
cally depend on the basic amino acid residues arginine3.6 versus 100  7.4%), a result consistent with the
similar high LBP augmentation of the bioactivity of these 94 and lysine 95, a mutant LBP containing glutamine
substitutions at these sites so as to eliminate bindingpreparations. Loss of glycan integrity by muramidase
digestion decreased LBP capture to 73 4.6% of whole of LPS (Lamping et al., 1996) was tested for binding to
PCW. Binding of the mutant LBP to PCW was 70% lessPCW, a result in agreement with the bioactivity assay.
Finally, completely fragmented, double-digested PCW, than wild-type LBP (Figure 6B). Taken together with
the competition results, these data suggested that thewhich was biologically inactive in solution, could capture
LBP when immobilized, albeit at a reduced amount (64 binding site for PCW might overlap that for LPS on LBP.
11.2% of whole PCW).
Discussion
The PCW Binding Region on LBP
To determine the structural requirement within the LBP The innate immune system recognizes major classes of
pathogens based on molecular patterns (Janeway andprotein needed for the LBP-PCW interaction, we first
assessed whether PCW could compete with LPS for Medzhitov, 2002). The pattern for Gram-positive patho-
gens has not been defined even though more than halfbinding to LBP. Preincubation of LBP with LPS signifi-
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positive, surface-exposed cell wall would be anticipated
to exist. Drosophila has been found to harbor several
such peptidoglycan recognition proteins, and one has
a potential homolog in humans (Michel et al., 2001; Liu
et al., 2001). This report reveals the surprising identity
of such a protein to be LBP, a protein historically thought
to be dedicated to Gram-negative infection. Here, we
report that LBP also plays an essential role in the innate
immune response to Gram-positive pneumococci and,
specifically, to their major inflammatory component,
PCW. The glycan backbone of PG seemed to be a crucial
structure for recognition by LBP, a finding that extends
the motif recognition capabilities of LBP from glycolipids
to complex, multimeric carbohydrates.
As an acute phase protein, a high serum concentration
of LBP has been reported in severe Gram-positive sep-
sis and is correlated to a poor outcome of disease (Opal
et al., 1999). We found significantly increased concentra-
tions of LBP in the CSF of patients with proven pneumo-
coccal meningitis. This suggests that this response is
not just collateral to activation of the acute phase re-
sponse but participates in specific immune recognition.
Leukocyte influx into the CSF, the hallmark of bacterial
meningitis, was drastically reduced in LBP null mice
compared to heterozygous mice with normal levels of
LBP. This was seen in PCW as well as in living pneumo-
Figure 5. Dependence of Binding of LBP on Structure of the PCW
cocci-induced meningitis. Furthermore, the reduction of
Direct binding of LBP to PCW and intact bacteria assessed in the
leukocytes in the LBP/ mice persisted for over 24ELISA assay. (A) LBP (2.5 g/ml) binding to immobilized PCW, cho-
hr after challenge and inflammation was restored byline-free PCW bearing ethanolamine (EA), and PCW lacking one of
resupplying exogenous rLBP. This is consistent with thetwo choline moieties (LicD2). (B) Anticholine mAb TEPC-15 binding
to PCW. Note lack of antibody binding to PCW EA confirms absence lack of symptoms of shock in galactosamine sensitized
of choline. (C) TNF- release at 6 hr from RAW 264.7 cells treated LBP/ mice injected intraperitoneally with LPS (Jack
with PCW fragments (5  106/ml CFU equivalents) was measured et al., 1997; Wurfel et al., 1997). Reducing leukocytes in
in the absence (open bars: 100%  2860  1024 pg/ml TNF-) the CSF is believed to be of potential therapeutic benefit
and presence (solid bars) of LBP (1 g/ml). Fragments immobilized:
because high numbers of CSF leukocytes correlate toPCW; PCW treated with trichloroacetic acid to remove the TA (PCW-
an unfavorable clinical outcome and the reduction ofTCA); PCW digested with amidase to sever stem peptides (PCW-A);
leukocytes is associated with a decrease of brainPCW digested with muramidase to break the glycan backbone
(PCW-M); PCW digested with both enzymes (PCW-AM). edema, intracranial pressure, hyperemia, neuronal dam-
age, and death (Tuomanen et al., 1989; Weber et al.,
1997; Braun et al., 1999). However, decreased inflamma-
of all invasive disease is caused by this class of bacteria. tory parameters, such as lower TNF concentrations and
Following the paradigm for LPS, a soluble binding pro- leukocytes, result in much higher bacterial numbers and
earlier death in LBP null animals with Salmonella sepsistein capable of recognizing key elements on the Gram-
Figure 6. Competition of LPS with PCW
Binding to LBP
(A) LBP at 1 g/ml (solid bars) or 2.5 g/ml
(open bars) was incubated with the indicated
concentration of LPS for 30 min and then al-
lowed to bind to immobilized PCW for 2 hr.
Captured LBP was detected by ELISA. (B)
The amount of wild-type (solid bar) or mutant
(open bar) LBP R94E/K95E bound to immobi-
lized PCW. * indicates a statistically signifi-
cant difference compared LBP binding with-
out LPS (A) or to normal LBP (B) (p  0.05).
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Figure 7. Model of LBP Binding to PCW: The Iterative Polyanionic Motif
The structural model of human LBP was calculated by the SWISS-MODEL server (Guex and Peitsch, 1997) utilizing the crystal structure of
human BPI (Protein Data Bank Code: 1BP1) as the template (Beamer et al., 1997). A series of basic residues in the N-terminal domain of LBP
is highlighted in white. Basic side chains in the apical region required for LPS binding are marked in yellow. Inset: mutant LBP (R94E/K95E)
with altered residues shown in red. Detailed chemical structures of intact PG (A) and PG digested with amidase (B) are shown with colored
arrows indicating the positions of PCW cleavage by trichloroacetic acid (green), amidase (blue), and muramidase (red) treatment, respectively.
In the presentation of pneumococcal PG (A), an average muropeptide structure displaying heterogeneity in the C-terminal stem peptide
residues (D-Ala or L-Lys) is shown. The -amino groups of the lysyl side chains have been identified to exist either in an unsubstituted form
(R: H), carrying dipeptide substituents (R: L-Ser-L-Ala or L-Ala-L-Ala), or forming direct as well as dipeptide-mediated crosslinking structures
to D-alanine residues in stem peptides of neighboring peptidoglycan strands (Garcia-Bustos et al., 1987; Garcia-Bustos and Tomasz, 1990;
Severin and Tomasz, 1996). Arrays of anionic residues (shaded in yellow) are iterative in both the repeating PG polymer and the repeating
glycan backbone. Such multimeric arrays are proposed to form a motif to contact the N-terminal domain of LBP as indicated by black arrows.
(Fierer et al., 2002; Heinrich et al., 2001; Yang et al., could not be blocked by an anti-CD14 antibody (Heu-
mann et al., 1994). It is tempting to speculate that the2002). Thus, attenuating LBP-dependent responses so
as to decrease the intensity of CNS inflammation and observed PCW/LBP binding and presentation to TLR-2
does not absolutely require CD14. However, further ex-damage would require preventing bacterial growth by
concomitant bactericidal antibiotic therapy to be suc- periments are needed to verify the role of CD14 in innate
immune activation by PCW and LBP. PCW signalingcessful.
On the cellular level, we found that augmentation of engages the TLR-2 but not the TLR-4 receptor. Recent
reports of TLR-4 involvement for Gram-positive bacteriaPCW inflammation by LBP is transduced through activa-
tion of the MAPK signaling pathway. Participation of (Dziarski and Gupta, 2000) were not supported by our
experiments.LBP effectively doubled the inherent PCW inflammatory
capability. PCW induces the phosphorylation of the The acute phase pentraxin CRP (Winkelstein and To-
masz, 1978) is an example of a circulating bacterial rec-MAPK erk1/2 in BMEC’s as shown here and in our previ-
ous experiments with astrocytes (Schumann et al., ognition protein participating in the innate immune re-
sponse, but its cell wall binding capability is restricted1998). LBP significantly augmented the release of TNF-
but not NO. This difference is consistent with recent to pneumococcus because PCW contains the unusual
element phosphorylcholine. Decreasing or completelyfindings that inhibition of the erk1/2 pathway decreases
TNF-, but not NO, release, and conversely, NO, but not eliminating the choline did not affect PCW recognition
by LBP. Thus, two acute phase proteins, CRP and LBP,TNF-, release is blocked by p38 inhibitors (Monier et
al., 2002). serve to recognize PCW but by distinct mechanisms.
It has been shown that PCW inflammatory activity inMAPK signaling and TNF- release were observed in
a serum-free system in BMEC that do not express a vivo and in vitro is retained despite degradation of the
TA (Tomasz, 1981). Similarly, the enhancing effect ofmembrane-bound CD14 receptor. In a previous study
using human monocytes, pneumococcal TNF- release LBP on PCW-induced cytokine release was also inde-
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pleocytosis of 	1000 cells/l with 	90% neutrophils and a positivependent of TA, suggesting that bioactivity and LBP rec-
culture for S. pneumoniae was required. LBP content was measuredognition are both related to the PG component of PCW.
by an ELISA using the monoclonal antibodies 1E8 and 2B5 as de-Using increasingly refined PCW components, both the
scribed previously (Zweigner et al., 2001).
inherent bioactivity of PCW and LBP’s ability to augment CSF cleared of cells was centrifuged (20,000 rpm), 25 l of the
PCW effects were clearly attributable to an intact PG supernatant or the pellet resuspended in 200 l PBS, applied to a
membrane. The blot was probed with TEPC-15 Ab (1:1000; Sigma,backbone. Whereas inherent bioactivity was lost by dis-
Deisenhofen, Germany) to detect cell wall and with anti LBP mAbruption of crosslinking by either the glycan backbone
(1:1000, a kind gift from XOMA, Berkeley, CA). As a positive control,(Majcherczyk et al., 1999) or stem peptides, LBP ap-
PCW incubated with rLBP (XOMA) was used.peared to bind in such a way as to salvage bioactivity of
the floppy PG held together only by peptide crosslinks.
Mouse Model of Meningitis
Complete loss of both peptide and PG backbone cross- Mouse experiments were conducted using a modification of a pre-
linking was required to eliminate LBP-dependent re- viously published model (Tang et al., 1996; Hoffmann et al., 2002).
sponses. This suggests that LBP recognizes a multimeric In brief, LBP/mice (Dr. R. Jack, University of Greifswald, Germany)
were bred at the Charite´ animal facility and were genotyped bystructure and that the motif can be compiled by carbohy-
PCR (Jack et al., 1997). Male LBP/ and LBP/ mice (20 g) weredrates in the absence of lipid. As typical high molecular
anesthetized, and 50 l saline containing 1  107 CFU equivalentsweight aggregates of LPS are selectively opsonized by
of PCW or 3  104 living pneumococci (D39) was injected into the
a layer of LBP molecules (Tobias et al., 1995; Iovine et spinal canal at the level of L2 or L3. CSF was collected after 6, 12,
al., 2002), an analogous recognition of multimeric PCW or 24 hr, and leukocytes were counted (Hoffmann et al., 2002). Some
by multiple LBP molecules may occur. of the animals were perfused and the brains were removed and
fixed for histological examination.In the three-dimensional model of human LBP, the
residues in positions 94 and 95 form the central part of
Cell Culture Systemsa conserved cluster of basic side chains in the apical
Primary cultures of BMEC were prepared from 3-week-old Wistarregion of the N-terminal domain (Beamer et al., 1997,
rats as previously published (Freyer et al., 1999), substituting the
1998b). This cluster includes the highly conserved basic medium with HAM’s F10 with 20% FCS, 2 mM L-Glutamine, 100
side chains in positions 42, 48, 92, and 99 that have U/ml Penicillin, 100 g/ml Streptomycin, 2.5 g/ml Amphotericin B,
been proposed to be mandatory for recognition of LPS 0.5 g/ml Vitamin C (Sigma), 8 g/ml ECGF (Roche; Mannheim,
Germany), and 80 g/ml heparin. All cell culture media and supple-by LBP and BPI proteins (Beamer et al., 1998a; Ferguson
ments were purchased from Biochrom (Berlin) unless otherwiseet al., 2000). Our findings of LPS competition and a
mentioned. The endothelial cells formed confluent monolayers afterdecreased recognition of PCW by the mutant LBP
6–8 days and were subsequently used for the experiments. 0.05%
(R94E/K95E) suggest that the PCW binding site on LPB of the cells stained positive for GFAP and 1% for OX-42 and CD14.
might structurally overlap that for LPS. Approximately 99% of the cultivated cells stained positive for von
The phosphate residues or equivalent anionic groups Willebrandt factor VIII (Dako, Hamburg, Germany).
The mouse macrophage cell line RAW 267.4 was grown in RPMIin the lipid A domain of LPS are major determinants for
1640 with 10% of FCS, 100 U/ml Penicillin, 100 g/ml Streptomycin,LPS or lipid A recognition by LBP and BPI (Tobias et
and 2 mM L-Glutamine. Cells were seeded at a density of 35,000al., 1989; Gazzano-Santoro et al., 1995). A common fea-
cells/cm2 in 24-well plates and used 2 days later.
ture in the PCW is a polyanionic character that is con-
ferred by free carboxyl groups in C-terminal stem pep-
Pneumococcal Cell Wall Preparations
tide residues or terminal lactosyl groups in muramic acid PCW were purified as described (Tuomanen et al., 1985) with minor
units exposed following amidase cleavage (Figure 7). modifications. Unencapsulated Streptococcus pneumoniae R6 was
cultured overnight in chemically defined media to 5  108 CFU/Therefore, we propose that the anionic groups found in
ml. The bacteria were heat-killed and disintegrated two times for 3an iterative arrangement in the stem peptides or along
min with a Bead Beater apparatus (Roth, Karlsruhe, Germany) bythe glycan backbone in polymeric PCW interact with the
using 0.1 mm beads. The suspension was digested with 10 g/mlapical basic side chains of the N-terminal domain of
DNase (Promega, Mannheim, Germany) and 50 g/ml RNase (USB
LBP, creating a recognition pattern (Figure 7). Corp., Cleveland, OH) for 1 hr at 37C followed by treatment with
A previously unrecognized pivotal role for LBP in im- 100 g/ml trypsin (plus 10 mM CaCl2; Sigma) for 2 hr at 37C. The
digest was sedimented by centrifugation (23,000 g, 20 min) andmune response to important Gram-positive infections
resuspended in 2% SDS (Serva, Heidelberg, Germany) at 90C forexpands its known role beyond LPS. This has several
20 min followed by eight cycles of washing. The purified cell wallsimportant ramifications. The polyanionic glycan scaffold
were resuspended in PBS at OD 620 nm  1 (equivalent of 108 CFU)of PCW recognized by LBP is shared by all bacteria
and were stored at 20C. The composition of the cell wall has
and therefore represents a possible overarching pattern been described (Garcia-Bustos and Tomasz, 1987).
suitable for broad, early immune recognition. This would The ethanolamine containing cell wall (R6EA) was prepared by an
identical procedure except that choline was replaced by 20 g/mlplace LBP at a critical nexus serving as a general soluble
ethanolamine (Sigma) in the growth medium (Tomasz et al., 1975).bacterial recognition receptor. Complete understanding
The cell wall derived from the licD2 mutant was prepared in theof these mechanisms of immune activation may create
same way except that the bacteria were grown in medium containingnovel opportunities for adjuvant therapy and for diagno-
erythromycin (1 g/ml; Sigma; Zhang et al., 1999). Teichoic acid-
sis in severe infections. free peptidoglycan was prepared from PCW by treatment with 5%
trichloroacetic for 30 min at 100C (Tuomanen et al., 1985).
Amidase-Digested PCWExperimental Procedures
Recombinant, affinity-purified pneumococcal N-acetylmuramoyl-
L-alanine amidase (amidase; Garcia-Bustos et al., 1987) was usedMeasurement of LBP Levels in Human CSF
Diagnostic CSF samples from five patients suffering from bacterial to hydrolyze the bonds between the glycan chains and the stem
peptides. PCW was treated with 100 units/ml of amidase for 18 hrmeningitis and nine samples from controls (i.e., patients in whom
CSF studies revealed no inflammatory changes whatsoever) were with shaking at 37C. Cell wall hydrolysates were centrifuged to
remove the undigested cell wall (15,000 g, 10 min) and the superna-included in the analysis. For a diagnosis of bacterial meningitis, CSF
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tant was then boiled for 10 min to inactivate the enzyme (Garcia- PCW-LBP Binding Assay
Nunc MaxiSorb ELISA plates were coated with different PCW prepa-Bustos and Tomasz, 1987).
Muramidase-Digested PCW rations or heat-killed pneumococci, respectively, by incubating the
plate with a coating buffer consisting of 100 mM Na2CO3, 20 mMTo hydrolyze the bonds between the N-acetylmuramoyl and N-acet-
ylglucosamine residues, N-acetylmuramoylhydrolase (muramidase, EDTA adjusted at a pH of 9.6, and 50 l/ml (2 107 CFU equivalents)
cell wall suspension for 3 hr at room temperature followed by threeEC 3.2.1.17; Sigma) was used as described (Tomasz, 1981; Majcher-
czyk et al., 1999). The enzyme was added to a final concentration times washing with H2O and drying. In order to block nonspecific
binding, BSA (5 mg/ml) dissolved in incubation buffer (50 mMof 10 g/ml and 1 mg/ml substrate in 0.25 mM potassium phosphate
buffer (pH 6.5) containing 5 mM magnesium chloride. The mixture HEPES, 150 mM NaCl, pH  7.4) was added overnight at 4C. After
removing the buffer, the coated plate was incubated with anticholinewas incubated for 24 hr with gentle shaking at 37C before boiling
to inactivate the enzyme. Fully digested material becomes nonsedi- TEPC-15 Ab (Sigma) diluted 1:125 in incubation buffer containing
BSA (1 mg/ml) for 2 hr in order to confirm PCW or pneumococcimentable by centrifugation (Garcia-Bustos and Tomasz, 1987).
Double-digested PCW was made by applying first the muramidase binding to the plates. Detection was carried out with a conjugated
anti-IgA-FITC labeled secondary antibody (1:250; Sigma). In orderfollowed by the amidase treatment. In all PCW preparations, the
LPS concentration was below the detection limit of the Limulus to assess LBP binding, recombinant murine LBP (1 g/ml unless
otherwise noted; see above), was added to the PCW, or pneumo-amebocyte lysate test (Bio Whitaker, Walkersville, MD).
cocci-coated plates. After incubation for 2 hr at 37C and repeated
washing with washing buffer, a monoclonal anti-LBP antibody
Expression and Purification of LBP (1:125; big 33, Biometec, Greifswald, Germany) was added and incu-
Murine LBP was expressed in a baculovirus system as described bated for another 2 hr, followed by detection with an anti-IgG FITC
(Lamping et al., 1998). For some experiments, we used commercially labeled secondary antibody (1:250; Sigma). After repeated washing,
available mLBP (Biometec, Greifswald, Germany). fluorescence was quantified at 485 and 530 nm in a fluorescence
The human mutant LBP R94/K95E and the control human LBP reader (Cyto Fluor, Perseptive Biosystems, Framingham, MA).
used for the experiment presented in Figure 6B were expressed in
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